News from dariohealth corp. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

May 19, 2022, 08:00 ET DarioHealth Announces Additional Commercial Contracts for its Digital Therapeutic Solutions

DarioHealth Corp. (NASDAQ: DRIO), a leader in the global digital therapeutics (DTx) market, announced today two new contracts to provide digital...

May 12, 2022, 06:30 ET DarioHealth Reports Record Quarterly Revenues in its 2022 First Quarter

Total Q1 revenue of $8.06 million increased 124% over the comparable prior year period and 34% sequentially over Q4 2021 Accelerated...

May 04, 2022, 08:00 ET DarioHealth to Report First Quarter 2022 Results on Thursday, May 12

DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, today announced it would release its financial results...

Apr 27, 2022, 08:02 ET DarioHealth Presents New Clinical Research Demonstrating Improved Outcomes for Participants Using a Single Integrated Digital Solution to Manage Multiple Chronic Conditions

DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced the publication of a retrospective, real-world...

Apr 14, 2022, 08:00 ET DarioHealth Announces Agreement with Health Plan Colorado Access

DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today a new agreement with Colorado Access, the ...

Mar 23, 2022, 08:00 ET DarioHealth Announces Additional New Employer Contracts

DarioHealth Corp. (NASDAQ: DRIO), a leader in the global digital therapeutics (DTx) market, announced today two new employer agreements: first, with...

Mar 22, 2022, 06:30 ET DarioHealth Reports Fourth Quarter and Full Year 2021 Results and Operational Highlights

DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, today reported financial results for the fourth quarter...

Mar 14, 2022, 08:00 ET DarioHealth to Report Fourth Quarter and Full Year 2021 Results on Monday, March 21

DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, today announced it would release its financial results...

Mar 09, 2022, 08:00 ET DarioHealth Announces Two New Contracts within the Employer and Provider Market

DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today new agreements with a regional employer...

Mar 07, 2022, 08:00 ET DarioHealth to Participate in the Cowen 42nd Annual Healthcare Conference

DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, today announced that management will participate in the...

Mar 01, 2022, 07:05 ET DarioHealth Enters into Strategic Agreement with Sanofi U.S.

DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced it has entered into a strategic agreement with...

Mar 01, 2022, 07:00 ET DarioHealth Announced Pricing of its Registered Direct Offering for Aggregate Proceeds of $40 Million Priced At-The-Market Under Nasdaq Rules

DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today that on February 28, 2022 it entered into ...

Feb 09, 2022, 08:00 ET DarioHealth Publishes Clinical Outcomes Demonstrating the Impact of Using a Single Digital Therapeutics Platform for Multiple Conditions

DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced the publication of a retrospective, real-world...

Feb 08, 2022, 08:00 ET DarioHealth Announces Four New Employer Contracts

DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, today announced several new contracts to deliver its...

Jan 20, 2022, 08:00 ET DarioHealth Enters Agreement to Acquire Physimax, a Leading Provider of Validated Computer Vision for Musculoskeletal Health

DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market (the Company), announced it has entered into an agreement...

Jan 19, 2022, 07:00 ET DarioHealth Enters into Agreement with Large Regional Health Plan

DarioHealth Corp. (NASDAQ-CM: DRIO), a leader in the global digital therapeutics (DTx) market, announced today it has contracted with a large...

Jan 18, 2022, 08:01 ET DarioHealth to Host Investor Webinar on Navigating Emerging Digital Health Trends for Strategic Growth in 2022

DarioHealth Corp. (Nasdaq: DRIO) a leader in the global digital therapeutics (DTx) market, today announced that it will host an investor webinar on...

Jan 06, 2022, 08:00 ET DarioHealth Announces Two New Contracts within the Employer Market

DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced two new contracts today to provide its highly...

Dec 21, 2021, 08:00 ET DarioHealth Selected as Exclusive Digital Therapeutics Provider to a Leading Benefits Brokerage

DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced a new strategic partnership with a leading...

Dec 02, 2021, 08:00 ET DarioHealth Announces Two New Contracts within the Employer and Provider Markets

DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced new contracts today to provide its highly...

Nov 18, 2021, 08:00 ET DarioHealth Announces Two New Employer Contracts

DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today that it has contracted with two employers ...

Nov 15, 2021, 17:00 ET DarioHealth Reports Third Quarter 2021 Results and Operational Highlights

DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today reported financial results for the third quarter of 2021 ...

Nov 15, 2021, 06:40 ET DarioHealth Appoints Seasoned Health Care Executive Jerrod Helms as Chief Commercial Officer

DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that the Company appointed Jerrod Helms to the ...

Nov 11, 2021, 06:40 ET DarioHealth Announces Three New Contracts as Growth Continues to Accelerate Across the Employer and Provider Markets

DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today that it has contracted with two new...

Nov 08, 2021, 06:40 ET DarioHealth to Report Third Quarter 2021 Results on Monday, November 15

DarioHealth Corp. (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, today announced it would release its financial results for the ...